Partnership between SMA Foundation, PTC Therapeutics, and Roche featured in article

Following the approval of Evrysdi, Roche released an article describing its partnership with the SMA Foundation and PTC Therapeutics to develop the drug.

To read the article, please visit: https://www.roche.com/partnering/spinal-muscular-atrophy-sma-together.htm